Squarepoint
IBB icon

Squarepoint’s iShares Biotechnology ETF IBB Stock Holding History

Squarepoint’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,653
Closed -$5.63M – 4533
2025
Q3 		$5M Sell
34,653
-30,789
-47% -$4.2M 0.01% 1473
2025
Q2 		$8.28M Sell
65,442
-6,554
-9% -$805K 0.01% 1172
2025
Q1 		$9.21M Buy
71,996
+66,702
+1,260% +$9.04M 0.01% 1068
2024
Q4 		$700K Buy
+5,294
New +$744K ﹤0.01% 3416
2024
Q2 		– Sell
-116,534
Closed -$15.6M – 4328
2024
Q1 		$16M Buy
116,534
+37,613
+48% +$5.14M 0.03% 726
2023
Q4 		$10.7M Buy
78,921
+61,530
+354% +$7.51M 0.02% 901
2023
Q3 		$2.13M Buy
+17,391
New +$2.21M 0.01% 1775
2022
Q4 		– Sell
-139,913
Closed -$16.4M – 3370
2022
Q3 		$16.4M Buy
+139,913
New +$17.4M 0.08% 278
2021
Q2 		– Sell
-140,804
Closed -$21.2M – 3438
2021
Q1 		$21.2M Buy
+140,804
New +$22.4M 0.12% 171
2020
Q4 		– Sell
-216,035
Closed -$29.3M – 3063
2020
Q3 		$29.3M Buy
+216,035
New +$29.3M 0.39% 34
2020
Q1 		– Sell
-156,186
Closed -$18.8M – 2154
2019
Q4 		$18.8M Buy
156,186
+68,303
+78% +$7.62M 0.11% 165
2019
Q3 		$8.74M Buy
87,883
+12,196
+16% +$1.28M 0.08% 324
2019
Q2 		$8.26M Buy
75,687
+57,133
+308% +$6.08M 0.08% 296
2019
Q1 		$2.07M Sell
18,554
-18,913
-50% -$2.07M 0.02% 756
2018
Q4 		$3.61M Buy
+37,467
New +$3.98M 0.04% 495
2018
Q3 		– Sell
-49,774
Closed -$5.47M – 2080
2018
Q2 		$5.47M Buy
+49,774
New +$5.32M 0.07% 377
2018
Q1 		– Sell
-16,789
Closed -$1.79M – 1895
2017
Q4 		$1.79M Buy
+16,789
New +$1.79M 0.03% 600
2017
Q2 		– Sell
-22,323
Closed -$2.18M – 1650
2017
Q1 		$2.18M Sell
22,323
-13,836
-38% -$1.32M 0.06% 372
2016
Q4 		$3.2M Sell
36,159
-15,204
-30% -$1.38M 0.13% 185
2016
Q3 		$4.96M Buy
+51,363
New +$4.89M 0.33% 68

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Squarepoint's IBB Position: Q4 2025 in Review

Squarepoint sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 34,653 shares — an estimated $5.63M sold.

Squarepoint first reported a position in IBB in Q3 2016 and held it in 20 quarters. The position peaked at $29.3M in Q3 2020. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Squarepoint reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 34,653 iShares Biotechnology ETF shares in Q4 2025, an estimated $5.63M.
  • Squarepoint first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 20 quarters.
  • Squarepoint's iShares Biotechnology ETF position peaked at $29.3M in Q3 2020.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.